Lanean...
Use of antibodies and immunoconjugates for the therapy of more accessible cancers
There are currently 6 unconjugated antibodies and 3 immunoconjugates approved for use in the Unites States in a variety of cancers, with a considerable number of new agents in clinical testing and preclinical development. Unconjugated antibodies alone can be effective, but more often, antibodies nee...
Gorde:
| Egile Nagusiak: | , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2008
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2575231/ https://ncbi.nlm.nih.gov/pubmed/18508155 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.addr.2008.04.011 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|